In this study, we identified galectin-1, galectin-9, and alpha-1-microglobulin as the circulating immunomodulatory proteins that are independently associated with 2-year MACE in patients with PAD, thereby acting as potential biomarkers for systemic atherosclerosis. This evidence concerns the gene LGALS9 and peripheral arterial disease.